Current Trends and Limitations in Dengue Antiviral Research.

Obi, Juliet O; Gutiérrez-Barbosa, Hernando; Chua, Joel V; Deredge, Daniel J

Obi, Juliet O; Gutiérrez-Barbosa, Hernando; Chua, Joel V; Deredge, Daniel J.

Afiliación

Obi JO; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
Gutiérrez-Barbosa H; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Chua JV; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Deredge DJ; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

Trop Med Infect Dis ; 6(4)2021 Sep 30.

Article en En | MEDLINE | ID: mdl-34698303

Palabras clave

NS5; antiviral targets; dengue virus; flavivirus; non-nucleoside inhibitors; nucleoside inhibitors; polymerase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Trop Med Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos